Israel Active

An AI tool from Israel’s Technion Institute helps combat antibiotic resistance. It reduced ineffective antibiotics prescribed for urinary tract infections by 35%. The tool was trialed by Israel’s Maccabi Health Management Organization (HMO) and will now be used for other infection types and HMOs.

Researchers from the Hebrew University of Jerusalem have discovered that some bacteria enter a “disrupted” state when attacked but not destroyed by antibiotics. A different chemical is then needed to “finish them off”, otherwise they can eventually recover and reproduce. See also .

Israel’s Ophthalmic Sciences has developed IOPerfect - the world’s first AI-based contactless intraocular pressure (IOP) measuring device. It allows those at risk of going blind from glaucoma, to measure their eye pressure anytime and anywhere and communicate the results to their doctor.

Israel’s Bio-fence (see previously) has completed a study showing that its antimicrobial paint additive extends the power of disinfectants. A major Israeli sausage manufacturing plant completely wiped out listeria after applying Bio-fence’s paint coating.

Israel’s TruLeaf Medical, part of Israel’s Allium Medical (see ) has developed a Transcatheter Mitral Valve Replacement (TMVR) solution to save the lives of numerous Mitral Regurgitation patients worldwide. The device has already completed animal studies and is set to be tested in humans soon.

Professor Hossam Haick’s lab at Israel’s Technion Institute (see previously) has developed a smart suture-less dressing that binds the edges of a wound together, wards off infection, and even digitally reports on the wound’s condition to the surgeon.

Israel’s Biolojic Design is developing an AI platform to generate antibodies that have specific targets and biological effects. It instructs the immune system to precisely attack the causes of disease, such as the mechanism underlying autoimmune disease, cancer or diabetes.  

Tel Aviv University Professor Noam Shomron has developed an AI tool that interprets routine hospital blood tests to assess patients at danger levels in the case of blood infection.  The tool is shortly to be trialed at Tel Aviv’s Sourasky (Ichilov) Medical Center.

An Israeli-led team of scientists have developed a blood test that analyzes fragments of DNA to determine the impact of the immune system. The test is like a liquid biopsy and can detect cancer early in remote tissues, e.g., bone marrow, lymph nodes and other organs.

Scientists at Tel Aviv University have developed an experimental molecule that breaks down the protein TDP-43, a key cause of ALS (Lou Gehrig’s disease). TDP-43 causes motor neurons to degenerate. The new molecule enabled motor neuron activity to be restored and opens the door to an ALS cure.